Followers | 822 |
Posts | 163138 |
Boards Moderated | 6 |
Alias Born | 09/23/2009 |
Monday, June 19, 2017 8:21:53 AM
Alert
VANCOUVER, BC - June 19,2017 - InvestorsHub NewsWire - Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE (the "Company" or "Enertopia") the Company provides the following information on phase 2 of its strategic plan with respect to its ongoing lithium exploration program.
The Company is very pleased that it has completed phase one of its field exploration program covering select locations in the Western USA and the Catamarca and Salta provinces of Argentina. All field samples collected by the Company's consultants are currently being analyzed by 3rd party labs.
The Company also attended the Lithium Conference in Argentina, whereby the Company has been successful in entering into discussions with Salar owners and active mining companies on taking part in our upcoming Phase two bench tests with Genesis Water Technologies (GWT).
The Company will provide further exploration and bench test updates as information becomes available. However, due to the very sensitive and competitive nature of these internal prospects being generated on public lands, the Company will keep exact project locations confidential until such time as the lands have been acquired.
We are very excited about our developments and are working aggressively on mapping out the next steps for phase two battery grade lithium carbonate purity bench testing and property acquisitions, stated President and CEO Robert McAllister
Recent ENRT News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/01/2024 06:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 03:41:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/11/2024 08:38:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 06:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 02:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 09:09:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 10:06:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 01:06:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/12/2023 08:29:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:24:54 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM